Notice Type
Departmental
Notice Title

Approval of a Lead Clinician to Provide Opioid Substitution Treatment Under Section 24A of the Misuse of Drugs Act 1975

Acting under delegated authority from the Minister of Health, I, Dr John Crawshaw:

  1. Revoke the approval of the Timaru Opioid Substitution Treatment Service and medical practitioner issued pursuant to section 24A(7)(a), (b) of the Misuse of Drugs Act 1975 on 17 January 2020 (as published in the New Zealand Gazette, 21 January 2020, Notice No. 2020-go234); and
  2. Specify the Timaru Opioid Substitution Treatment Service as a service that may provide treatment with controlled drugs for people who are dependent on controlled drugs, pursuant to section 24A(7)(b) of the Misuse of Drugs Act 1975, at the following place:

    Timaru Hospital
    Kensington Centre
    Queen Street
    Timaru 7910; and

  3. Pursuant to section 24A(7)(a) of the Misuse of Drugs Act 1975, specify that Dr Cecilia Smith-Hamel, as a medical practitioner, may:
    1. prescribe, administer or supply controlled drugs for the treatment of dependence as the lead clinician for Timaru Opioid Substitution Treatment Service;
    2. authorise in writing service/clinic medical practitioners as specified under subsection 24A(2)(b) to:
      1. prescribe, administer or supply controlled drugs for the treatment of dependence;
      2. authorise in writing general practitioners receiving clients from Timaru Opioid Substitution Treatment Service as specified under section 24A(2)(d) of the Misuse of Drugs Act 1975; and
    3. authorise in writing general practitioners receiving clients from Timaru Opioid Substitution Treatment Service as specified under section 24A(2)(b) of the Misuse of Drugs Act 1975.

Conditions

  1. Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Timaru Opioid Substitution Treatment Service.
  2. This approval will take effect on 5 March 2020.
  3. This approval expires on 31 December 2020.

Dated at Wellington this 5th day of March 2020.

Dr JOHN CRAWSHAW, Director of Mental Health, Mental Health and Addictions.